⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ANAB News
AnaptysBio, Inc. Common Stock
Vanda Pharmaceuticals announces the publication of "Efficacy and Safety of Imsidolimab for Generalized Pustular Psoriasis" in NEJM Evidence
prnewswire.com
VNDA
ANAB
Form 8-K/A
sec.gov
ANABV
ANAB
Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim
globenewswire.com
ANAB
Form 8-K
sec.gov
ANAB
ANABV
Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations
globenewswire.com
TRAX
ANAB
Form 8-K
sec.gov
ANAB
Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update
globenewswire.com
TRAX
ANAB
First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement
globenewswire.com
ANAB
Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics
globenewswire.com
ANAB
Form 8-K
sec.gov
ANAB